109951 ⎘
dsDNA viruses; Details; Papillomaviridae Virus like particles [VLP]
TRUNCATED RECOMBINANT L1 PROTEIN OF HUMAN PAPILLOMAVIRUS
#2CONTROLLED RELEASE VACCINE FORMULATIONS
#3Virus-Like Particle Conjugates
#4CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#5CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#6CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#7CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#8CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#9CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#10CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#11CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#12CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#13CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#14CHIMERIC PAPILLOMAVIRUS L1 PROTEIN
#15NANOEMULSION ADJUVANT COMPOSITIONS FOR HUMAN PAPILLOMAVIRUS VACCINES
#16CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES
#17HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF
#18VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
#19Universal vaccine platform
#20MODIFIED HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN AND USE THEREOF
#21CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS
#22Virus-like particle conjugates
#23Virus-like particle conjugates for diagnosis and treatment of tumors
#24Chimeric papilloma virus L1 protein
#25Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
#26METHOD FOR THE EXPANSION OF HPV IMMUNOGEN SPECIFIC T-CELLS
#27TARGETED COMBINATION THERAPY
#28Virus-like particle conjugates for diagnosis and treatment of tumors
#29VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
#30Universal vaccine platform
#31HPV vaccine
#32Mutant of L1 protein of human papillomavirus type 18
#33Mutant of L1 protein of human papillomavirus type 39
#34Serologic test for therapy control of HPV16 positive carcinoma
#35Non-human papillomaviruses for gene delivery in vitro and in vivo
#36Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
#37Mutant of L1 protein of human papillomavirus type 58
#38Virus-like particle conjugates for diagnosis and treatment of tumors
#39Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
#40Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
#41EFFICIENT CELL FREE PRODUCTION OF PAPILLOMAVIRUS GENE TRANSFER VECTORS
#42Virus-like particle conjugates
#43Universal vaccine platform
#44Papillomavirus pseudoviruses for detection and therapy of tumors
#45HPV particles and uses thereof
#46Serologic test for therapy control of HPV16 positive carcinoma
#47Virus-like particle conjugates for diagnosis and treatment of tumors
#48Mutant of L1 protein of human papillomavirus type 11
#49Virus like particle with efficient epitope display
#50Inflammasome activators and methods of use to treat tumors
#51Truncated L1 protein of human papillomavirus type 11
#52METHODS FOR POTENTIATING AN IMMUNE RESPONSE USING DEPOT-FORMING AND NON-DEPOT-FORMING VACCINES
#53Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease
#54HPV particles and uses thereof
#55POLYIONIC PAPILLOMA VIRUS-LIKE PARTICLE (VLP) VACCINES
#56HPV vaccine formulations comprising aluminum adjuvant and methods of producing same
#57Microneedle-based transdermal delivery system and method of making same
#58IMMUNOGENIC HPV L2-CONTAINING VLPS AND RELATED COMPOSITIONS, CONSTRUCTS, AND THERAPEUTIC METHODS
#59Truncated L1 protein of human papillomavirus type 11
#60Virus-like particle conjugates for diagnosis and treatment of tumors
#61Truncated L1 protein of human papillomavirus type 58
#62Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines
#63RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR
#64Plant produced human papillomavirus pseudovirion
#65Nanoparticle synthesis using plant extracts and virus
#66Papillomavirus pseudoviruses for detection and therapy of tumors
#67Recombinant virus-like particles encoded by multi-gene vector
#68HPV chimaeric particle
#69Genes encoding major capsid protein L1 of human papilloma virus
#70Truncated L1 protein of human papillomavirus type 33
#71Polyionic papilloma virus-like particle (VLP) vaccines
#72Truncated L1 protein of human papillomavirus type 58
#73Truncated L1 protein of human papillomavirus type 52
#74Papillomavirus pseudoviruses for detection and therapy of tumors
#75Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
#76Papillomavirus virus-like particle or capsomere formulation and its use as microbicide
#77Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods
#78Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
#79Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
#80PAPILLOMAVIRUS VACCINE COMPOSITIONS
#81HPV particles and uses thereof
#82METHOD OF PREPARATION OF A BIOLOGICAL PARTICULATE STRUCTURE
#83Papilloma Pseudovirus and Preparation
#84ENHANCED PRODUCTION OF PAPILLOMAVIRUS-LIKE PARTICLES WITH A MODIFIED BACULOVIRUS EXPRESSION SYSTEM
#85Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
#86Vaccine for cervical cancer
#87Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines
#88NOVEL COMPOSITIONS
#89THERAPEUTIC AND PROPHYLACTIC VACCINE FOR THE TREATMENT AND PREVENTION OF PAPILLOMAVIRUS INFECTION
#90RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR
#91SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY
#92Genes encoding major capsid protein L1 of human papilloma virus
#93METHOD FOR PRODUCING YEAST EXPRESSED HPV TYPES 6 AND 16 CAPSID PROTEINS
#94SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES
#95Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production
#96DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#97Truncated L1 protein of human papillomavirus type 11
#98Truncated L1 protein of human papillomavirus type 18
#99Optimized expression of HPV 58 L1 in yeast
#100RESPIRATORY SYNCYTIAL VIRUS VACCINE BASED ON CHIMERIC PAPILLOMAVIRUS VIRUS-LIKE PARTICLES OR CAPSOMERES
#101Papilloma pseudovirus and preparation
#102PAPILLOMAVIRUS VACCINE COMPOSITIONS
#103CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES
#104Papillomavirus pseudoviruses for detection and therapy of tumors
#105Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
#106Optimized expression of HPV 52 L1 in yeast
#107Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
#108Papilloma virus vaccine
#109Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
#110Chimeric papillomavirus-like particles
#111Virus-Like Particle Containing A Dengue Recombinant Replicon
#112Method for producing yeast expressed HPV types 6 and 16 capsid proteins
#113VACCINE
#114Virus-like particle containing a Dengue virus recombinant replicon
#115Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
#116Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles
#117Papilloma virus capsomere vaccine formulations and methods of use
#118DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#119Mixture of human papillomavirus virus-like particles
#120Immunomodulating Compositions and Uses Therefor
#121Papillomavirus vaccine compositions
#122Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
#123Optimized expression of HPV 52 L1 in yeast
#124Virus-like particles for the induction of autoantibodies
#125Optimized expression of HPV 31 L1 in yeast
#126Optimized expression of HPV 45 L1 in yeast
#127Chimeric papillomavirus-like particles
#128Vaccine composition comprising virus-like particles of human papillomavirus
#129Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
#130Papilloma virus vaccine
#131Method for producing yeast expressed HPV types 6 and 16 capsid proteins
#132Method of making a genetically modified mammalian cell
#133Optimized expression of HPV 58 L1 in yeast
#134Vaccine
#135Composition
#136Self-assembling recombinant papillomavirus capsid proteins
#137Hpv-16 and-18 l1 vlp vaccine
#138Optimized expression of HPV 45 L1 in yeast
#139Virus-like particles for the induction of autoantibodies
#140Papilloma virus capsomere vaccine formulations and methods of use
#141Optimized expression of HPV31 L1 in yeast
#142Papilloma virus-like particles, fusion proteins as well as processes for their production
#143Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
#144Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles
#145Virus-like particle containing a dengue virus recombinant replicon
#146Vaccine
#147Papilloma virus truncated L1 protein and fusion protein constructs
#148Treatment of papillomavirus infections
#149Mixed Virus-like particles
#150Vaccine composition comprising virus-like particles of human papillomavirus
#151Papilloma pseudovirus and preparation
#152Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
#153Chimeric papillomavirus-like particles
#154Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas
#155Synthetic virus-like particles with heterologous epitopes
#156Papilloma virus capsomere vaccine formulations and methods of use
#157Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles